Serina Therapeutics Inc (SER)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Serina Therapeutics Inc Stock (SER) Company Profile

Serina Therapeutics Inc

Healthcare (1107)

Biotechnology (621)

(256) 327-9630

601 GENOME WAY, HUNTSVILLE

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SER's Discussions on Twitter

Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SER Serina Therapeutics Inc	2.04	28.65M	130.00K	-21.29M	-18.29M	-1.977
VRTX Vertex Pharmaceuticals Inc	453.17	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.73	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	878.49	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	281.90	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	156.58	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-14	Eingeleitet	H.C. Wainwright	Buy

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc Stock (SER) Company Profile

Compare SER vs VRTX, REGN, ARGX, ALNY, RVMD

Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades

Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten

Insider Buying: Karen Wilson Acquires Shares of Serina Therapeutics Inc (SER) - GuruFocus

Serina Therapeutics director Karen Wilson buys $17,749 common stock By Investing.com - Investing.com India

Serina Therapeutics director Karen Wilson buys $17,749 common stock - Investing.com UK

Director Karen J. Wilson boosts Serina (SER) stake with 10,100-share purchase - Stock Titan

Serina Therapeutics Inc. (SER) Q1 2026 Earnings: Losses Wider Than Expected as Pre-Revenue Biotech Continues Clinical DevelopmentFinal Results - newsline.com

Serina Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Serina Therapeutics (SER) Stock Price, News & Analysis $SER - MarketBeat

Serina Therapeutics (SER) Gains 4% as It Tests Key Resistance at $1.90BPI Bull Confirmed - newsline.com

Serina Therapeutics (SER) Tests Key Support After Modest DeclineDealer Delta - newsline.com

SER Q1 2026 Earnings: EPS Misses Estimates as Development-Focused Biotechnology Firm Continues Pipeline ProgressEarnings Revision Upgrade - newsline.com

SER News | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

[EFFECT] Serina Therapeutics, Inc. SEC Filing - Stock Titan

Serina Therapeutics (SER) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Company Reports Wider Loss - thelegaladvocate.com

Serina Therapeutics Inc. Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Navigates Development CostsEarnings Volatility Report - The Legal Advocate

Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN

Serina Therapeutics (SER) grants CEO 10,100 common shares - Stock Titan

Serina Therapeutics (SER) SVP granted 85,558 stock options at $1.89 - Stock Titan

Serina Therapeutics (SER) CEO awarded 380,825 stock options - Stock Titan

Serina Therapeutics (SER) CFO awarded 123,019 stock options at $1.89 - Stock Titan

Serina Therapeutics (SER) CSO receives 85,558 stock options at $1.89 strike - Stock Titan

Serina Therapeutics (SER) Faces Headwinds: Shares Decline 3% Toward Support at $1.82Break of Structure - The Legal Advocate

Serina Therapeutics director Karen Wilson buys $37,000 in shares By Investing.com - Investing.com India

Serina Therapeutics director Karen Wilson buys $37,000 in shares - Investing.com

Director boosts stake in Serina Therapeutics (SER) with 20K-share buy - Stock Titan

Serina Therapeutics (SER) Faces Selling Pressure, Tests Key Support LevelsMAMA Signal - thelegaladvocate.com

Serina Therapeutics (SER) Slips 6% as Stock Approaches Key Support LevelGap Down Bounce Plays - thelegaladvocate.com

Serina Therapeutics Inc (SER) Q1 2026 Earnings: EPS Miss Amid Continued Development ProgressFinancial Summary - Newser

Serina Therapeutics Q1 2026 Earnings: EPS Misses Estimates as Stock Climbs Despite LossGAAP Earnings Report - Newser

Serina Therapeutics Inc. (SER) Recovers 4.93% as Stock Approaches Key Resistance at $2.08Volume Spike Alerts - Newser

Serina Therapeutics Inc. (SER) Gains Nearly 5% as Stock Approaches Key ResistanceTop Analyst Buy Signals - Newser

Director at Serina Therapeutics (SER) makes open-market buy of 12,183 shares - Stock Titan

16.45M Serina shares registered for resale (NYSE: SER) - Stock Titan

Serina Therapeutics : Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi - marketscreener.com

SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

Serina Therapeutics (SER) Gets a Buy from JonesTrading - The Globe and Mail

Insider-Backed PIPE Deal May Dilute Serina Therapeutics Shareholders and Heighten Governance Risks - The Globe and Mail

Serina Therapeutics 1Q Loss/Shr 58c >SER - Moomoo

Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - The Manila Times

Parkinson's drug trial moves ahead as Serina adds $21.2M funding - Stock Titan

Serina Therapeutics (NYSE: SER) raises $21.2M and advances SER-252 trial - Stock Titan

Serina Therapeutics (NYSE: SER) posts Q1 loss and raises $21.2M PIPE amid cash risk - Stock Titan

SER Technical Analysis | Trend, Signals & Chart Patterns | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill

Finanzdaten der Serina Therapeutics Inc-Aktie (SER)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SER